ASLAN Pharmaceuticals Ltd (ASLN)
0.4749
-0.01
(-1.06%)
USD |
NASDAQ |
May 22, 16:00
0.45
-0.02
(-5.24%)
After-Hours: 20:00
ASLAN Pharmaceuticals Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2018 | -0.0078M |
| September 30, 2018 | -0.9091M |
| June 30, 2018 | -10.08M |
| March 31, 2018 | -12.09M |
| December 31, 2017 | -0.0147M |
| September 30, 2017 | -0.115M |
| Date | Value |
|---|---|
| June 30, 2017 | -0.137M |
| March 31, 2017 | -0.0698M |
| December 31, 2016 | -0.1441M |
| September 30, 2016 | -0.2582M |
| June 30, 2016 | -0.0779M |
| March 31, 2016 | -0.0433M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Dr Reddy's Laboratories Ltd | -139.12M |
| Concord Medical Services Holdings Ltd | -- |
| Zai Lab Ltd | 3.292M |
| WAVE Life Sciences Ltd | -0.417M |
| CytoMed Therapeutics Ltd | -- |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -756.9% |